FOX CHASE CANCER CENTER – Temple Health formed a partnership with Accutest Research Laboratories for joint work on clinical trials.
The partnership aims to offer a research platform to conduct clinical trials in the United States, India, Southeast Asia and Latin America. Representatives of both organizations signed a non-binding memorandum of understanding on Nov. 10 in New Delhi.
Accutest was founded in 1998, and offers end-to-end services to pharmaceutical and biotechnology companies. Its services include phase I bioavailability/bioequivalence studies, phase II – IV clinical development services and biosimilars services, covering clinical operations, clinical data management, pharmacovigilance, and medical writing services.
